市場調查報告書
商品編碼
1450991
2024-2032 年等溫核酸擴增技術市場報告(按產品、技術、應用、最終用戶和地區分類)Isothermal Nucleic Acid Amplification Technology Market Report by Product, Technology, Application, End-User, and Region 2024-2032 |
2023年,全球等溫核酸擴增技術(INAAT)市場規模達到31億美元。展望未來, IMARC Group預計到2032年市場規模將達到79億美元,2024年複合年成長率(CAGR)為 10.8%。2032 .
等溫核酸擴增技術 (INAAT) 用於分子生物學和重組 DNA 技術中,用於檢測和鑑定核酸。它通常用於在恆溫下擴增核酸,從而無需熱循環儀設備。主要用於RNA、DNA、細胞、蛋白質、小分子和離子,以確保遺傳性疾病、遺傳性疾病和傳染病的快速、敏感和準確的診斷。它產生的擴增子用於生產多功能核酸奈米材料。除此之外,它還有助於檢測各種傳染病,例如(HIV)、結核病、流感、甲型和乙型肝炎、衣原體和淋病(CT/NG)。因此,INAAT 在全球範圍內獲得了巨大的關注。
用於檢測冠狀病毒病(COVID-19)的 INAAT 的持續開發是積極影響市場的關鍵因素之一。與此一致的是,全球老年人口的增加、癌症和其他慢性疾病盛行率的上升,以及對有效診斷和治療替代方案的需求不斷增加,正在促進市場成長。除此之外,採用環介導等溫擴增 (LAMP) 測試來擴增 DNA 和 RNA 以及基因改造生物 (GMO) 的鑑定正在催化對 INAAT 的需求。此外,鏈置換擴增(SDA)、單引子等溫擴增(SPIA)和重組酶聚合酶擴增(RPA)的發展是另一個生長誘導因子。此外,領先市場參與者增加對研發(R&D)活動的投資預計將推動市場發展。
The global isothermal nucleic acid amplification technology (INAAT) market size reached US$ 3.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 7.9 Billion by 2032, exhibiting a growth rate (CAGR) of 10.8% during 2024-2032.
The isothermal nucleic acid amplification technology (INAAT) is used in molecular biology and recombinant DNA technologies for detecting and identifying nucleic acids. It is commonly used to amplify nucleic acids at a constant temperature, thereby eliminating the need for thermocycler equipment. It is majorly utilized for RNA, DNA, cells, proteins, small molecules, and ions to ensure the rapid, sensitive and accurate diagnosis of genetic, inherited, and infectious diseases. It generates amplicons that are employed in producing versatile nucleic acid nanomaterials. Besides this, it assists in detecting various infectious diseases, such as (HIV), tuberculosis, influenza, hepatitis A and B, chlamydia, and gonorrhea (CT/NG). As a result, INAAT is gaining immense traction across the globe.
The ongoing development in INAAT for detecting coronavirus disease (COVID-19) represents one of the key factors positively influencing the market. In line with this, the increasing geriatric population globally and the rising prevalence of cancer and other chronic medical disorders, along with the escalating demand for efficient diagnosis and treatment alternatives, are contributing to the market growth. Apart from this, the adoption of loop-mediated isothermal amplification (LAMP) tests to amplify DNA and RNA and the identification of genetically modified organisms (GMOs) is catalyzing the demand for INAAT. Furthermore, the development of strand displacement amplification (SDA), single primer isothermal amplification (SPIA), and recombinase polymerase amplification (RPA) are acting as another growth-inducing factor. Moreover, increasing investments in research and development (R&D) activities by leading market players are projected to drive the market.
IMARC Group provides an analysis of the key trends in each sub-segment of the global isothermal nucleic acid amplification technology market report, along with forecasts at the global, regional, and country level from 2024-2032. Our report has categorized the market based on product, technology, application, and end-user.
Instruments
Reagents
Reagents hold the majority of the global isothermal nucleic acid amplification technology market share due to their increasing use in therapeutics.
Helicase-Dependent Amplification (HDA)
Nicking Enzyme Amplification Reaction (NEAR)
Loop-Mediated Isothermal Amplification (LAMP)
Strand Displacement Amplification (SDA)
Nucleic Acid Sequence-Based Amplification (NASBA)
Transcription Mediated Amplification (TMA)
Single Primer Isothermal Amplification (SPIA)
Others
TMA accounts for the majority of the total market share as it allows a clinical laboratory to perform nucleic acid test (NAT) assays for blood screening with fewer steps and less processing time.
Infectious Disease Diagnosis
Hepatitis
CT/NG
HIV
Influenza
Others
Blood Screening
Others
Infectious disease diagnosis currently dominates the market due to the rising prevalence of infectious diseases across the globe.
Hospitals
Diagnostic Laboratories
Research Laboratories
Others
Hospitals presently dominate the market due to the increasing number of hospitals and significant development in the healthcare industry.
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
North America exhibits a clear dominance in the market due to the shifting consumer preference for INAAT testing over traditional diagnostic procedures.
The competitive landscape of the market has been analyzed in the report, along with the detailed profiles of the major players operating in the industry. Some of these players are Abbott Laboratories, bioMerieux SA, Becton, Dickinson and Company, Eiken Chemical Co. Ltd., Hologic Inc., Meridian Bioscience Inc., OptiGene Limited, Thermo Fisher Scientific Inc., Tecan Trading AG, and Ustar Biotechnologies Ltd.